Published in Gene Therapy Weekly, March 28th, 2002
University of Tennessee investigators have reported one of the first studies to examine the practicality and effectiveness of delivering gene therapy to prostate cancer tumors using a transrectal route. According to their report, the method represents a strategic way to direct adenoviruses encoded for therapeutic genes into malignant prostate cells although a minimal level of systemic dissemination can be expected.
The technique makes use of ultrasound to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.